Tricia R Cottrell

7PUBLICATIONS
65CO-AUTHORS
Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 08, 2025
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses.

Joshua E Reuss, Paul K Lee, Reza J Mehran

|Nov 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade.

Samuel Rosner, Sydney Connor, Khaled Sanber

|Oct 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancer.

Julie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson

|Apr 21, 2022
Immune cell subsets in interface cutaneous immune-related adverse events associated with anti-PD-1 therapy resemble acute graft versus host disease more than lichen planus.

Guillermo E Almodovar Cruz, Genevieve Kaunitz, Julie E Stein

|Oct 05, 2021
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.

Justina X Caushi, Jiajia Zhang, Zhicheng Ji

|Jul 22, 2021
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers.

Justina X Caushi, Jiajia Zhang, Zhicheng Ji

Pageof 2

Frequent Collaborators

5 joint publications

Janis Taube

4 joint publications

Julie S Deutsch

4 joint publications

Kellie N Smith

4 joint publications

Valsamo Anagnostou